SCM
COGT icon

Sterling Capital Management’s Cogent Biosciences COGT Stock Holding History

Sterling Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Sell
586
-567
-49% -$19.8K ﹤0.01% 1829
2026
Q1 		$44.4K Sell
1,153
-165
-13% -$6.09K ﹤0.01% 1686
2025
Q4 		$46.8K Buy
1,318
+499
+61% +$14K ﹤0.01% 1830
2025
Q3 		$11.8K Buy
819
+466
+132% +$5.52K ﹤0.01% 2403
2025
Q2 		$2.54K Buy
353
+155
+78% +$859 ﹤0.01% 2853
2025
Q1 		$1.19K Sell
198
-107
-35% -$839 ﹤0.01% 2759
2024
Q4 		$2.38K Buy
305
+198
+185% +$1.97K ﹤0.01% 2736
2024
Q3 		$1.16K Buy
+107
New +$1.04K ﹤0.01% 2454

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sterling Capital Management's COGT Position: Q2 2026 in Review

Sterling Capital Management reduced its Cogent Biosciences (COGT) stake by 49% in Q2 2026, selling an estimated $19.8K and leaving 586 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Sterling Capital Management first reported a position in COGT in Q3 2024 and has held it in 8 quarters since. The position peaked at $46.8K in Q4 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Sterling Capital Management held 586 shares of Cogent Biosciences worth $22.7K as of Q2 2026.
  • Sterling Capital Management sold 567 Cogent Biosciences shares in Q2 2026, an estimated $19.8K.
  • Cogent Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1829 holding.
  • Sterling Capital Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Cogent Biosciences position peaked at $46.8K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.